Merck Hires Ex-CDC Chief; New PBM Boss at CVS


Published On: December 22nd, 2009

MerckA couple interesting hires in corporate health-care were announced today:

Julie Gerberding, the doctor who ran the CDC from 2002 until early this year, will head Merck’s vaccine unit, the company said. Vaccines are a $5 billion business for Merck; the previous head of the group retired earlier this year. Merck seems to be rounding out its exec team. The company said last week that it hired the dean of Tufts med school to fill a top spot. And earlier this month, the company named a former Wyeth guy to head up vaccines and biologics manufacturing, Dow Jones Newswires notes.

CVS Caremarkhired Per Lofberg to run its pharmacy-benefits-management business. The company said last month that its PBM unit, which manages prescription-drug benefits for employers and other institutions, lost nearly $5 billion in contracts. (Since then, the group did manage to land a $500 million per year contract with a Texas pension fund.) Lofberg was chairman of the PBM Medco back when it was owned by Merck. More recently, he was running a company called Generation Health that is supposed to do for genetic testing what PBMs do for prescription drugs. Lofberg will succeed Howard McClure, who retired last month.

Photo: Associated Press

More here: 
Merck Hires Ex-CDC Chief; New PBM Boss at CVS

STOP PANIC ATTACKS - A Natural Technique To Stop Panic Attacks and Anxiety Fast!

Stop Panic Attacks
The technique I teach has been developed by me Joe Barry, a former sufferer of all too frequent panic attacks and GAD. I developed a completely natural approach to eliminating 100% of general anxiety and panic attacks. This may seem very hard to believe for someone who may have had this condition for some time but believe me the new information is now available to be free from anxiety. I will reveal the whole technique to you.

try-now

YouTube Video



Loading...


Did You Know Did you know:


Prostate: 155.4 per 100,000 men per year

Related Posts

  • Turmoil at FDA! Device Chief Out, Drug Chief Investigated
    It’s an FDA two-fer this morning, with an investigation of one senior official and the departure of another. Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research , is under investigation for an alleged conflict of interest, the WSJ reports ..
  • Microsoft Buys Genetic Data Software from Merck
    Microsoft continues its push into health care, inking a deal with Merck to gain access to some genetic data-management software. The software giant said yesterday it was acquiring certain assets of Rosetta Biosoftware, a unit of Rosetta Inpharmatics, a company near Seattle that Merck acquired in 2001. Rosetta makes use of powerful computers and gene..
  • New FDA Boss Plans Changes
    WSJ’s Alicia Mundy details the background of new FDA Commissioner Margaret “Peggy” Hamburg and her mission in leading the troubled agency, including changing its focus from regulation to public health. ..
  • Help Wanted: Memorial Sloan-Kettering Seeks New Boss
    It’s a tough job market, but if you’ve won a Nobel Prize and run the NIH, we may have a gig for you. ..
  • New Merck Management: A Lot Like the Old Merck Management
    Merck just described what the company’s new management team will look like after the company’s merger with Schering-Plough goes through (assuming it’s cleared by regulators). The bottom line: Several key people in top positions at Merck will keep their jobs in the combined company. Dick Clark, Merck’s CEO, will run the combined show. ..
  • Pfizer Exec’s New Gig: Chief of Staff for Jersey Governor
    Chris Christie, governor-elect of New Jersey, said his chief of staff will be Rich Bagger, Pfizer’s SVP of global public affairs. Bagger, 49 years old, previously spent more than a decade in the state Legislature, the the Star-Ledger notes . ..
Leave a comment
Comments are closed.
« GE Sues a Doctor for Libel AMA, Hospitals Back Senate Health Bill; Insurers Still Opposed »